Provided by Tiger Trade Technology Pte. Ltd.

Biogen

181.46
-1.9500-1.06%
Post-market: 181.460.00000.00%19:04 EDT
Volume:2.21M
Turnover:402.23M
Market Cap:26.62B
PE:20.64
High:183.69
Open:183.13
Low:180.47
Close:183.41
52wk High:202.41
52wk Low:110.04
Shares:146.70M
Float Shares:146.23M
Volume Ratio:2.45
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.79
EPS(LYR):8.79
ROE:7.39%
ROA:6.14%
PB:1.46
PE(LYR):20.64

Loading ...

Biogen Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 21

Biogen, Eisai Report Long-Term Data Showing Patients Choose to Stay on Lecanemab Treatment

MT Newswires Live
·
Mar 21

Biogen, Eisai report findings from analysis of long-term treatment with LEQEMBI

TIPRANKS
·
Mar 21

Real-world US claims analysis shows 78.4% lecanemab persistence at 18 months in Biogen-Eisai study

Reuters
·
Mar 21

Results From Real-World, Long-Term Treatment Persistence With Leqembi® (Lecanemab-Irmb) in the United States Presented at Ad/Pd™ 2026

THOMSON REUTERS
·
Mar 21

US court certifies Biogen securities class action for June 8–July 12, 2021 purchasers

Reuters
·
Mar 19

Biogen to present late-breaking litifilimab Phase 2 AMETHYST data at AAD Annual Meeting

Reuters
·
Mar 19

Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 18

U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson

Reuters
·
Mar 17

Biogen : HSBC Raises Target Price to $150 From $143

THOMSON REUTERS
·
Mar 17

Stoke Therapeutics FY2025 revenue rose 100% to USD 184.42 million as net loss narrowed 92.26% to USD 6.89 million

Reuters
·
Mar 17

Biogen Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Mar 13

Jefferies Reaffirms Their Buy Rating on Biogen (BIIB)

TIPRANKS
·
Mar 12

Biogen - Susan H. Alexander, Chief Legal Officer, to Depart Effective End of May 2026 - SEC Filing

THOMSON REUTERS
·
Mar 12

Biogen Chief Legal Officer Susan H. Alexander to depart at end of May 2026

Reuters
·
Mar 12

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 12

Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Biogen (BIIB)

TIPRANKS
·
Mar 12

Biogen presents Phase 1b salanersen data showing 75% NfL reductions in children with SMA after gene therapy

Reuters
·
Mar 11

Biogen - All Participants Treated With Salanersen Experienced Improvement From Baseline on One or More Endpoints

THOMSON REUTERS
·
Mar 11